SCHEMBL2025901

SCHEMBL2025901

COc1ccc(CCc2cn3c(N)nnc3c(N)n2)cc1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.48
ATM Q13315 2/20 0.43
KDM4E B2RXH2 1/20 0.43
DHFR P00374 1/20 0.40
HTT P42858 1/20 0.40
AOC3 Q16853 1/20 0.40
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
POLB P06746 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
ADORA2A P29274 2/20 0.38
ADORA1 P30542 1/20 0.38
LMNA P02545 1/20 0.38
TSHR P16473 1/20 0.38
HSP90AB1 P08238 1/20 0.38
BLM P54132 1/20 0.38
PMP22 Q01453 1/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2019846 0.89 ALDH1A1 (0.48) CYP19A1ATMKDM4EDHFRHTT
SCHEMBL2018800 0.84 DHFR (0.46) ATMKDM4EDHFRALDH1A1HPGD
SCHEMBL2023558 0.77 DHFR (0.43) DHFRPOLBADORA2AADORA1
SCHEMBL2021765 0.77 DHFR (0.43) DHFRPOLBADORA2AADORA1HSP90AB1
SCHEMBL2026371 0.75 HPSE (0.43) DHFRALDH1A1CYP1A2ADORA2AADORA1
SCHEMBL2025903 0.71 CYP19A1 (0.48) CYP19A1ATMKDM4EDHFRHTT
SCHEMBL31157848 0.69 CYP19A1 (0.77) CYP19A1ATMKDM4EAOC3ALDH1A1
SCHEMBL16641094 0.69 CYP19A1 (0.77) CYP19A1ATMKDM4EAOC3ALDH1A1
SCHEMBL2024812 0.68 ADORA2A (0.46) KDM4EALDH1A1CYP3A4ADORA2AADORA1
SCHEMBL12476793 0.68 MAPT (0.52) ATMKDM4EHTTPOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8329705-B2 Substituted triazolo-pyrazine compounds ARQULE, INC. (US) 2012-12-11 US disclosed
US-20110160215-A1 Substituted Triazolo-Pyrazine Compounds ARQULE, INC. (US) 2011-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110160215-A1 Substituted Triazolo-Pyrazine Compounds MKI67, TP53, THPO CYP19A1 493/4885ATM 977/4885KDM4E 3014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.